Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

159.74
Delayed Data
As of Jan 20
 -0.84 / -0.52%
Today’s Change
119.37
Today|||52-Week Range
186.88
+24.76%
Year-to-Date
IBM Corp (IBM) Beats on Q4 Earnings; FY17 View Positive
Jan 20 / Zacks.com - Paid Partner Content
Will 2017 Be Illumina's Best Year Yet?
Jan 13 / MotleyFool.com - Paid Partner Content
Rockefeller Financial Services Inc Buys Facebook Inc, Synchrony Financial, Cemex SAB ...
Jan 19 / GuruFocus News - Paid Partner Content
IBM Watson Commerce Adopted by Ernes to Boost Profitability
Jan 13 / Zacks.com - Paid Partner Content
Did Roche Just Hand Illumina Pacific Biosciences Head on a Platter?
Jan 19 / MotleyFool.com - Paid Partner Content
Illumina and Bio-Rad Unveil Single-Cell Sequencing Solution
Jan 12 / Zacks.com - Paid Partner Content
Illumina (ILMN) Q4 Earnings: A Beat in Store for the Stock?
Jan 18 / Zacks.com - Paid Partner Content
Stock Market News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content
5 Healthcare Stocks Poised for Maximum Gains in 2017
Jan 17 / MotleyFool.com - Paid Partner Content
Why Illumina, Brookdale Senior Living, and Allscripts Healthcare Solutions Jumped Tod...
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close160.58
Today’s open160.90
Day’s range158.73 - 161.50
Volume1,364,832
Average volume (3 months)1,502,289
Market cap$23.6B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+0.34%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+19.25%
P/E ratio53.6
Price/Sales12.89
Price/Book12.73

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.05+0.21%
TECHBio-Techne Corp+0.02+0.02%
NBIXNeurocrine Bioscienc...-0.35-0.84%
XONIntrexon Corp-0.20-0.85%
Data as of 4:14pm ET, 01/20/2017

Financials

Next reporting dateFebruary 1, 2017
EPS forecast (this quarter)$0.81
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Chief Financial Officer &
Senior Vice President
Sam A. Samad
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs